Onph stock rating & prediction

WebTop Stocks in Biotechnology. Inozyme Pharma Inc. 89bio Inc. Immuneering Corporation. 435 Merchant Walk Square, Suite 300-145. Charlottesville, VA 22902. US: +1 800 698 … Web4 de jun. de 2024 · Sell candidate since 2024-02-07 Loss -57.90% PDF. The Oncology Pharma stock price fell by -4.46% on the last day …

ONPH stock climbs over 47 times in 2024 amid a series of

WebONPH Stock. USD 0.39 0.01 2.50%. Oncology Pharma stock price prediction is an act of determining the future value of Oncology Pharma shares using few different conventional … WebAverage Return. -91.50%. initiated a buy rating 12 months ago. Copying Nathan Weinstein 's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -91.50% per trade. inay\\u0027s place https://bobtripathi.com

Oncology Pharma - ONPH - Stock Price Today - Zacks

Web17 de jul. de 2024 · Get The Latest ONPH Stock Forecast, Price Target, and Headlines at MarketBeat. Skip to main content. S&P 500 (+0.19%) DOW (+0.30%) QQQ 315.93 … Web16 de ago. de 2024 · Little-known pharmaceutical company Oncology Pharma (OTCPK:ONPH +1.5%) has climbed nearly 4,000% as indicated by the graph. According … inay\\u0027s kitchen ocoee

ET Energy Transfer LP Analyst Estimates & Rating – WSJ

Category:Oncology Pharma Pink Sheet target price prediction (USA …

Tags:Onph stock rating & prediction

Onph stock rating & prediction

Agenus (AGEN) Stock Forecast, Price Targets and Analysts Predictions …

WebBased on analysts offering 12 month price targets for ONPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Web6 de abr. de 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for NetEase stock is Buy based on the current 5 buy ratings for NTES. The average twelve-month price prediction for NetEase is $112.67 with a high price target of $132.00 and a low price target of $95.00. Learn more on NTES's analyst rating history.

Onph stock rating & prediction

Did you know?

WebCompany profile page for Oncology Pharma Inc including stock price, company news, press releases, executives, board members, and contact information. Skip To Content. Skip to content. Web31 de mar. de 2024 · The average twelve-month price prediction for Expeditors International of Washington is $100.50 with a high price target of $122.00 and a low price target of $87.00. Learn more on EXPD's analyst rating history. Do Wall Street analysts like Expeditors International of Washington more than its competitors?

WebTop Stocks in Biotechnology. Inozyme Pharma Inc. 89bio Inc. Immuneering Corporation. 435 Merchant Walk Square, Suite 300-145. Charlottesville, VA 22902. US: +1 800 698 9101. International: +1 434 293 9100. WebBased on 9 analysts offering ratings for Parker Hannifin Corp. Buy. Strong Buy. 4 analysts 44.44%. Buy. 2 analysts 22.22%. Hold. 3 analysts 33.33%. Sell. 0 analysts 0%. Strong Sell. ... The average Parker Hannifin stock price prediction forecasts a potential upside of 16.95% from the current PH share price of $317.98. What is PH's forecast ...

Web21 de mar. de 2024 · View Oncology Pharma Inc ONPH investment & stock information. Get the latest Oncology Pharma Inc ONPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Web10 de mar. de 2024 · Review the latest analysis on Oncology Pharma Inc (ONPH:PINX) stock to find out if this stock is the best investment for you based on Morningstar's analysis.

Web7 de abr. de 2024 · See the latest Oncology Pharma Inc stock price (PINX:ONPH), related news, valuation, dividends and more to help you make your investing decisions.

Web3 de set. de 2024 · View live Oncology Pharma Inc chart to track its stock's price action. Find market predictions, ONPH financials and market news. inchikeyWebNasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ... inchikey to inchiWebGet the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. inchikey 转换WebSee Oncology Pharma Inc. (ONPH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. inchikey是什么意思WebFind the latest Oncology Pharma Inc. (ONPH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. inchikey 検索WebAnalyst Recommendations. The current consensus among 1 polled investment analysts is to Outperform stock in Oncology Pharma Inc. This rating has held steady since May, when it was downgraded from ... inay\u0027s kitchen menuWebHá 22 horas · This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of ... inchikey smiles